PrEP

Six months in, province celebrates uptake for free HIV prevention drugs

By

VANCOUVER-The Ministry of Health is reporting strong success six months into a program expanding coverage of HIV prevention medications. On Jan. 1, the province began covering the costs of preexposure prophylaxis treatment, also known as PrEP, for patients deemed at-risk. On Tuesday, Minister Adrian Dix announced that so far 1,944 people have received free PrEP, […]

Six months in, province celebrates uptake for free HIV prevention drugs Read More »

Thousands of British Columbians benefiting from no-cost HIV prevention treatment: Health Minster

By

VANCOUVER (NEWS 1130) – More than 2,000 people in this province have benefited from the expanded coverage of drugs that can prevent HIV infection. Health Minister Adrian Dix called BC’s treatment “world-leading” at an announcement this morning. “There are an estimated 7,271 British Columbians living with HIV today. Preventing new infections and giving people the

Thousands of British Columbians benefiting from no-cost HIV prevention treatment: Health Minster Read More »

Implants for Delivery of Antiretroviral Drugs for HIV Pre-Exposure Prophylaxis

By

Strategies to reduce new HIV infections span multifaceted efforts, including safe-sex counseling, voluntary medical male circumcision, treatment as prevention, and pre- (PrEP) and postexposure prophylaxis. PrEP entails the use of antiretroviral (ARV) drugs prophylactically by HIV-negative individuals at risk of infection to thwart acquisition of the virus. In 2012, the US Food and Drug Administration

Implants for Delivery of Antiretroviral Drugs for HIV Pre-Exposure Prophylaxis Read More »

‘Game-changer’ HIV prevention drug could be leading to lower condom use: studies

By

Pre-exposure prophylaxis, commonly known as PrEP, is a “game-changer” when it comes to preventing HIV infections, doctors say. But some new studies are suggesting that people who take it use condoms less often – increasing their risk of contracting other sexually-transmitted infections. PrEP is a combination of two drugs, initially used to treat HIV. But

‘Game-changer’ HIV prevention drug could be leading to lower condom use: studies Read More »

As death toll from HIV/AIDS wanes, new models for primary care emerge from decades of HIV experience

By

When celebrated author and alternative medicine advocate Deepak Chopra visited Palm Springs in early February, he had an epiphany. Invited to be a featured speaker in the Palm Springs Speaks lecture series, he visited Desert AIDS Project before his event that evening. While touring the campus Chopra realized he was seeing the real-life manifestation of

As death toll from HIV/AIDS wanes, new models for primary care emerge from decades of HIV experience Read More »

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search